Haemonetics Stock Target Price and Analyst Consensus
| HAE Stock | USD 65.52 0.41 0.62% |
The current analyst and expert consensus on Haemonetics is Strong Buy, with 3 strong buy opinions. The current projected Haemonetics target price consensus is 110.80 with 10 analyst opinions. Check out Macroaxis Advice on Haemonetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.The most common way Haemonetics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Haemonetics executives and customers to further validate their buy or sell advice. Haemonetics buy-or-sell recommendation module provides average expert sentiment on the projected Haemonetics target price to derive its highest and lowest estimates based on projected price volatility of 2.6894.
Lowest Forecast 100.83 | Highest Forecast 122.99 | Target Price 110.8 |
Haemonetics |
It's important to approach Haemonetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Haemonetics Target Price Consensus
Haemonetics target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Haemonetics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 10 | Strong Buy |
Most Haemonetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Haemonetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Haemonetics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationHaemonetics Target Price Projection
Haemonetics' current and average target prices are 65.52 and 110.80, respectively. The current price of Haemonetics is the price at which Haemonetics is currently trading. On the other hand, Haemonetics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Haemonetics Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Haemonetics Target Price
Haemonetics Analyst Ratings
Haemonetics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Haemonetics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Haemonetics' financials, market performance, and future outlook by experienced professionals. Haemonetics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Haemonetics price targets
Haemonetics' stock target price is an estimate of its future price, usually made by analysts. Using Haemonetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Haemonetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Haemonetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Haemonetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Haemonetics is a key component of Haemonetics valuation and have some predictive power on the future returns of a Haemonetics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Cash Cows Invested few shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Haemonetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Please note, the presentation of Haemonetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Haemonetics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Haemonetics' management manipulating its earnings.